Upadacitinib

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2224 publications

Real-world effectiveness of abrocitinib and upadacitinib in atopic dermatitis: a propensity-matched analysis.

Real-world effectiveness of abrocitinib and upadacitinib in atopic dermatitis: a propensity-matched analysis.

Journal: The Journal of dermatological treatment

Published: September 07, 2026

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: September 05, 2026

Reasons for Upadacitinib Discontinuation and Risk of Recurrence in the Treatment of Atopic Dermatitis.

Reasons for Upadacitinib Discontinuation and Risk of Recurrence in the Treatment of Atopic Dermatitis.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: August 31, 2026

Rare manifestations of giant cell arteritis

Rare manifestations of giant cell arteritis

Journal: Lakartidningen

Published: August 27, 2026

Cardiovascular and Thromboembolic Risk With Upadacitinib in Spondyloarthritis and Inflammatory Bowel Disease: A Meta-Analysis of Randomized Controlled Trials.

Cardiovascular and Thromboembolic Risk With Upadacitinib in Spondyloarthritis and Inflammatory Bowel Disease: A Meta-Analysis of Randomized Controlled Trials.

Journal: Journal of cardiovascular pharmacology

Published: August 19, 2026

Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.

Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.

Journal: JAMA dermatology

Published: August 12, 2026

Rapid resolution of generalized pustular psoriasis with upadacitinib.

Rapid resolution of generalized pustular psoriasis with upadacitinib.

Journal: JAAD case reports

Published: August 09, 2026

Real-world retrospective study with upadacitinib in patients with severe alopecia areata: A series of 23 cases.

Real-world retrospective study with upadacitinib in patients with severe alopecia areata: A series of 23 cases.

Journal: JAAD case reports

Published: August 08, 2026

Upadacitinib for recalcitrant extragenital morphea and lichen sclerosus overlap: A case report.

Upadacitinib for recalcitrant extragenital morphea and lichen sclerosus overlap: A case report.

Journal: JAAD case reports

Published: August 08, 2026

Clinical Characteristics and Time to Onset of JAK-Inhibitor-Associated Acne: A Retrospective Chart Review Study.

Clinical Characteristics and Time to Onset of JAK-Inhibitor-Associated Acne: A Retrospective Chart Review Study.

Journal: Journal of drugs in dermatology : JDD

Published: August 05, 2026

Psoriasiform Dermatitis Following JAK Inhibitor Therapy for Hidradenitis Suppurativa and Crohn's Disease.

Psoriasiform Dermatitis Following JAK Inhibitor Therapy for Hidradenitis Suppurativa and Crohn's Disease.

Journal: Cureus

Published: August 05, 2026

Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic.

Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic.

Journal: Journal of internal medicine

Published: August 05, 2026

Showing 1-12 of 2,224

Last Updated: 09/26/2026